 OncoSec Medical Incorporated NASDAQ:ONCS the Company or OncoSec, a company developing late-stage intratumoral cancer immunotherapies, today announced that it has received a Research and Development RD; Tax Incentive cash rebate of 850,000 from the Australian Tax Office. 